• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Successful Risk Adjustment Improves Gap Closures: A Real-World Success Story from a Large Regional Health Plan

News
Article

Risk adjustment can be an effective solution for identifying potential gaps in care among beneficiaries. But payers face numerous challenges navigating the risk adjustment landscape.

Learn how one regional health plan’s goals were achieved or exceeded year upon year with steadily improved completion of provider alerts through an ongoing partnership with Veradigm, a pairing for success.

This paper provides insight into how Veradigm helped one large regional health insurer overcome numerous challenges to strengthen their risk adjustment program, investing together in people and processes, as well as product solutions, to achieve measurable success, including:

  • Closure of appropriate risk adjustment gaps
  • Clinician feedback on conditions not applying to members
  • Achievement of more accurate and complete risk scores, allowing them to deploy the right interventions, with the right providers, at the right times

Complete the form below to download the whitepaper.

Sponsored by

© 2024 MJH Life Sciences

All rights reserved.